Comtex SmarTrend Alert

  • FREE MORNING CALL NEWSLETTER
  • Login Here
  • Sign Up
  • HOME
  • NEWS & ANALYSIS
  • RESEARCH
  • PERFORMANCE
  • TV
  • PRICING
  • RESOURCES
  • TESTIMONIALS
  • ABOUT
  •         
Somaxon Pharmaceuticals has the Highest Sales Growth in the Pharmaceuticals Industry (SOMX, OPTR, VRX, QCOR, SLXP)
Thursday, February 9, 2012 - 06:00
Optimer Pharmaceuticals Crosses Above its 10-day MA (OPTR)
Friday, January 27, 2012 - 14:27
Shares of Optimer Pharmaceuticals Rank the Lowest in Terms of EPS Growth in the Pharmaceuticals Industry (OPTR, MRX, JNJ, MRK, ABT)
Friday, January 20, 2012 - 04:00
Shares of Optimer Pharmaceuticals Rank the Lowest in Terms of EPS Growth in the Pharmaceuticals Industry (OPTR, MRX, JNJ, MRK, ABT)
Wednesday, December 21, 2011 - 04:02
Watch for Optimer Pharmaceuticals to Potentially Rebound After Falling 2.20% Yesterday
Monday, December 19, 2011 - 18:05
After Yesterday's Rally of 4.70% Shares Could Potentially Pullback
Friday, December 16, 2011 - 17:44
Possible Bearish Inside Day Candle Pattern Detected for Optimer Pharmaceuticals (NASDAQ:OPTR)
Wednesday, December 7, 2011 - 14:57
Relatively Good Performance Detected in Shares of Optimer Pharmaceuticals in the Pharmaceuticals Industry (OPTR, LLY, SHPGY, SNY, PFE)
Wednesday, December 7, 2011 - 06:32
Top 5 Companies in the Pharmaceuticals Industry With the Best Relative Performance (ELN, JAZZ, OPTR, PRGO, MYL)
Tuesday, December 6, 2011 - 06:33
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Auxilium Pharmaceuticals (AUXL, HITK, MDCO, OPTR, PRGO)
Monday, December 5, 2011 - 06:29



Facebook Twitter YouTube RSS Widget Blog Digg
  • Home
  • About
  • News Briefs
  • Archives
  • Testimonials
  • Participating Sources
  • FAQ
  • Get Started
  • Contact Us
  • Advertise with Us
  • Privacy Statement
  • Sitemap

Comtex News Network, Inc. is not a registered investment advisor and does not provide investment advice.

Copyright 2012 Stock Market Trends and Technical Analysis by Comtex News Network, Inc.